DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded by StockNews.com to Buy Rating

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Friday.

Other equities research analysts also recently issued reports about the company. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating and reduced their target price for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Mizuho assumed coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price for the company. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Finally, Robert W. Baird reduced their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Nine investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $26.33.

DENTSPLY SIRONA Price Performance

XRAY stock traded down $0.45 during trading hours on Friday, hitting $18.76. 1,454,966 shares of the stock traded hands, compared to its average volume of 2,340,175. The stock has a 50-day simple moving average of $19.13 and a 200 day simple moving average of $22.29. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $34.91. The company has a market cap of $3.73 billion, a P/E ratio of -9.06, a P/E/G ratio of 1.88 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. During the same period in the prior year, the business posted $0.49 earnings per share. DENTSPLY SIRONA’s revenue was up .4% compared to the same quarter last year. Equities analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Cooke & Bieler LP raised its stake in shares of DENTSPLY SIRONA by 24.3% during the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after purchasing an additional 1,794,391 shares in the last quarter. FMR LLC raised its stake in shares of DENTSPLY SIRONA by 5.1% during the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after purchasing an additional 436,031 shares in the last quarter. Pacer Advisors Inc. raised its stake in shares of DENTSPLY SIRONA by 15,105.1% during the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after purchasing an additional 4,473,972 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of DENTSPLY SIRONA by 27.9% during the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock worth $45,611,000 after purchasing an additional 523,692 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of DENTSPLY SIRONA by 1.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock worth $39,880,000 after purchasing an additional 35,360 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.